E-LIB Suche - Ergebnisse für: Mould, Diane R.

1

"Getting the Dose Right"—Revisiting the Topic With Focus on..:

Mould, Diane R. ; Upton, Richard N.
Clinical Pharmacology & Therapeutics. , 2024

Link: https://doi.org/10.1002/..

2

Development of a Weight-Band Dosing Approach for Vosoritide..:

Qi, Yulan ; Chan, Ming Liang ; Mould, Diane R....
Clinical Pharmacokinetics. 63 (2024) 5 - p. 707-719 , 2024

Link: https://doi.org/10.1007/..

3

Comparative Analysis of Posiphen Pharmacokinetics across Di..:

Maccecchini, Maria L. ; Mould, Diane R.
Biomolecules. 14 (2024) 5 - p. 582 , 2024

Link: https://doi.org/10.3390/..

4

Tumor growth inhibition modeling in patients with second li..:

Milenković‐Grišić, Ana‐Marija ; Terranova, Nadia ; Mould, Diane R....
CPT: Pharmacometrics & Systems Pharmacology. 13 (2023) 1 - p. 143-153 , 2023

Link: https://doi.org/10.1002/..

5

Application of a Precision‐Dosing Model to a Real‐World Coh..:

Nguyen, Anke L. ; Gibson, Peter R. ; Upton, Richard N...
The Journal of Clinical Pharmacology. 64 (2023) 4 - p. 399-409 , 2023

Link: https://doi.org/10.1002/..

6

Disease progress models:

, In: Atkinson's Principles of Clinical Pharmacology,

Mould, Diane R. ; Holford, Nicholas H.G. ; Peck, Carl C. - p. 389-403 , 2022

Link: https://doi.org/10.1016/..

7

Contributors:

, In: Atkinson's Principles of Clinical Pharmacology,

Abernethy, Darrell R. ; Agoram, Balaji ; Allen, John M.... - p. xvii-xx , 2022

Link: https://doi.org/10.1016/..

8

Dashboard-Driven Accelerated Infliximab Induction Dosing In..:

Dubinsky, Marla C ; Mendiolaza, Michelle L ; Phan, Becky L...
Inflammatory Bowel Diseases. 28 (2022) 9 - p. 1375-1385 , 2022

Link: https://doi.org/10.1093/..

9

EP1309: SUBTHERAPEUTIC DOSING OCCURS IN ONE-THIRD OF PATIEN..:

Nguyen, Anke ; Gibson, Peter R. ; Mould, Diane R...
Gastroenterology. 162 (2022) 7 - p. S-1096-S-1097 , 2022

Link: https://doi.org/10.1016/..

10

Effect of Pevonedistat, an Investigational NEDD8‐Activating..:

Zhou, Xiaofei ; Richardson, Debra L. ; Dowlati, Afshin...
Clinical Pharmacology in Drug Development. 12 (2022) 3 - p. 257-266 , 2022

Link: https://doi.org/10.1002/..

11

Model Informed Precision Dosing Tool Forecasts Trough Infli..:

Primas, Christian ; Reinisch, Walter ; Panetta, John C....
Journal of Clinical Medicine. 11 (2022) 12 - p. 3316 , 2022

Link: https://doi.org/10.3390/..

12

Population Pharmacokinetics and Exposure‐Safety Relationshi..:

Zhou, Xiaofei ; Mould, Diane R. ; Yuan, Ying...
The Journal of Clinical Pharmacology. 62 (2022) 2 - p. 206-219 , 2022

Link: https://doi.org/10.1002/..

13

Personalized Dosing of Infliximab in Patients With Inflamma..:

Desai, Devendra C. ; Dherai, Alpa J. ; Strik, Anne.
The Journal of Clinical Pharmacology. 63 (2022) 4 - p. 480-489 , 2022

Link: https://doi.org/10.1002/..

14

Su469 TUMOR NECROSIS FACTOR IMPACTS INFLIXIMAB CLEARANCE IN..:

Young, Leslie ; Dervieux, Thierry ; Panetta, John C....
Gastroenterology. 160 (2021) 6 - p. S-706 , 2021

Link: https://doi.org/10.1016/..

15

Approaches to handling missing or "problematic" pharmacolog..:

Irby, Donald J. ; Ibrahim, Mustafa E. ; Dauki, Anees M....
CPT: Pharmacometrics & Systems Pharmacology. 10 (2021) 4 - p. 291-308 , 2021

Link: https://doi.org/10.1002/..